Medical Research

ORNL: Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer. In partnership with the National Cancer Institute, or NCI, researchers from the Department of Energy’s Oak Ridge National...

Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...

Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...

Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by...

The application, known as iStar, was created by Perelman School of Medicine researchers to give clinicians more insights into gene activities in medical images and, potentially, help them diagnose cancers that might have otherwise been...

OR

platinum partners

gold partners

Silver Partners

Media Partners